# ClinicalTrials.gov record NCT02384122

> PeptideScanner retained ClinicalTrials.gov record NCT02384122 at 2026-07-30T19:13:03.754Z. Its registry update date was 2023-05-24, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct02384122-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-05-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02384122-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02384122-octreotide-v1.json
- Content SHA-256: `a8f9a44b6a340d40e6e5cfe9db4d7217f7308513c46b88b76cc330c7dae84c9a`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02384122 ([`ctg-observation-nct02384122-2023-05-24-b7ed48cf8281`](#source-ctg-observation-nct02384122-2023-05-24-b7ed48cf8281))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02384122 at 2026-07-30T19:13:03.754Z. Its registry update date was 2023-05-24, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02384122-2023-05-24-b7ed48cf8281`](#source-ctg-observation-nct02384122-2023-05-24-b7ed48cf8281))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02384122 at 2026-07-30T19:13:03.754Z. Its registry update date was 2023-05-24, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02384122-2023-05-24-b7ed48cf8281`](#source-ctg-observation-nct02384122-2023-05-24-b7ed48cf8281))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02384122-2023-05-24-b7ed48cf8281`](#source-ctg-observation-nct02384122-2023-05-24-b7ed48cf8281))

## Sources

<a id="source-ctg-observation-nct02384122-2023-05-24-b7ed48cf8281"></a>
- **ClinicalTrials.gov record NCT02384122 · retained source version 2023-05-24:b7ed48cf8281840e72aba65669cab493ba385f4d02f4ad4a16520d59ed8c0edf** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02384122) (`ctg-observation-nct02384122-2023-05-24-b7ed48cf8281`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02384122." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02384122-octreotide-v1.json SHA-256: a8f9a44b6a340d40e6e5cfe9db4d7217f7308513c46b88b76cc330c7dae84c9a.